Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results : (57) Arrow Down
Filter Results : (57) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (484)
    • Faculty Publications  (57)

    Show Results For

    • All HBS Web  (484)
      • Faculty Publications  (57)

      Health Testing And Trials Remove Health Testing And Trials →

      Page 1 of 57 Results →

      Are you looking for?

      Health Testing and Trials
      Skip to Main Content Cold Call A podcast featuring faculty discussing cases they've written and the lessons they impart. Subscribe on iTunes 29 Sep...
      The Race for a Vaccine
      Above: illustration by Matthew Roharik/Getty Images In November 2019, a team from the National Institute of Allergy and Infectious Diseases, part of...
      → Search All HBS Web
      • October 2020
      • Teaching Plan

      Merck: COVID-19 Vaccines

      By: Willy C. Shih
      COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,...  View Details
      Keywords: Vaccines; health Pandemics; health testing And trials; Innovation And Management; Innovation Strategy; Research And Development; Business Strategy; Pharmaceutical Industry; United States
      Citation
      Purchase
      Related
      Shih, Willy C. "Merck: COVID-19 Vaccines." Harvard Business School Teaching Plan 621-067, October 2020.
      • October 2020
      • Case

      COVID-19 Testing at Everlywell

      By: Jeffrey J. Bussgang and Olivia Hull
      In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the...  View Details
      Keywords: Entrepreneurship; Business Strategy; Venture Capital; health Care And Treatment; health Disorders; Leading Change; Technology Adoption; Technology Platform; Competitive Strategy; Science; Adaptation; Corporate Social Responsibility And Impact; Crisis Management; Social Entrepreneurship; Ethics; Government Legislation; health; health testing And trials; health Pandemics; Consumer Products Industry; health Industry; Technology Industry; Texas; United States
      Citation
      Educators
      Purchase
      Related
      Bussgang, Jeffrey J., and Olivia Hull. "COVID-19 Testing at Everlywell." Harvard Business School Case 821-001, October 2020.
      • September 2020
      • Case

      Merck: COVID-19 Vaccines

      By: Willy C. Shih
      COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,...  View Details
      Keywords: Vaccines; health Pandemics; health testing And trials; Innovation And Management; Innovation Strategy; Technological Innovation; Business Strategy; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Shih, Willy C. "Merck: COVID-19 Vaccines." Harvard Business School Case 621-028, September 2020.
      • September 2020
      • Case

      Minerva 2020: Clinical Trials

      By: John R. Wells and Benjamin Weinstock
      In March 2020, Dr. Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Inc. (Minerva), was reviewing the first results of human clinical trials for the company’s novel CAR-T drug therapeutic, one of the first ever to target solid cancer tumors. The results...  View Details
      Keywords: Biotechnology; Strategic Decision Making; Entrepreneurship; health testing And trials; Decision Choices And Conditions; Strategy
      Citation
      Educators
      Purchase
      Related
      Wells, John R., and Benjamin Weinstock. "Minerva 2020: Clinical Trials." Harvard Business School Case 721-391, September 2020.
      • September–October 2020
      • Article

      The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

      By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
      Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused...  View Details
      Keywords: Gene Therapy; Gene Editing; Impact; health Care And Treatment; Technological Innovation; health testing And trials; Venture Capital; Change
      Citation
      Find at Harvard
      Read Now
      Related
      Pian, Julia, Amitabh Chandra, and Ariel Dora Stern. "The Past, Present, and (Near) Future of Gene Therapy and Gene Editing." NEJM Catalyst Innovations in Care Delivery 1, no. 5 (September–October 2020).
      • Article

      Quantifying the Use of Connected Digital Products in Clinical Research

      By: Caroline Marra, Jacqueline L. Chen, Andrea Coravos and Ariel D. Stern
      Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g.,...  View Details
      Keywords: Connected Digital Products; Clinical Trials; health testing And trials; Technology; Research
      Citation
      Read Now
      Related
      Marra, Caroline, Jacqueline L. Chen, Andrea Coravos, and Ariel D. Stern. "Quantifying the Use of Connected Digital Products in Clinical Research." Art. 50. npj Digital Medicine 3 (2020).
      • March 30, 2020
      • Article

      Why Is the U.S. Behind on Coronavirus Testing?

      By: Stefan Thomke
      Coronavirus testing is needed to address the uncertainty in making decisions about patient treatment, resource allocation, policy, and so much more. Answers to questions such as “When should we relax social distancing measures—and for whom?” or “How many ventilators...  View Details
      Keywords: testing; Coronavirus; Culture; Trump; Data; Experiments; health Pandemics; health testing And trials; Government And Politics; United States
      Citation
      Find at Harvard
      Read Now
      Related
      Thomke, Stefan. "Why Is the U.S. Behind on Coronavirus Testing?" Harvard Business Review Digital Articles (March 30, 2020).
      • February 2020
      • Teaching Note

      Theranos: Who Has Blood on Their Hands? (A) and (B)

      By: Nien-he Hsieh and Christina R. Wing
      Teaching Note for HBS Nos. 619-039 and 320-091.  View Details
      Keywords: health testing And trials; Corporate Accountability; Organizational Culture; Misleading And Fraudulent Advertising; Crime And Corruption; Lawsuits And Litigation; Medical Devices And Supplies Industry; California; United States
      Citation
      Purchase
      Related
      Hsieh, Nien-he, and Christina R. Wing. "Theranos: Who Has Blood on Their Hands? (A) and (B)." Harvard Business School Teaching Note 620-102, February 2020.
      • February 2020
      • Case

      Theranos: Who Has Blood on Their Hands? (B)

      By: Nien-he Hsieh, Christina R. Wing and John Masko
      This supplemental case tracks the results of the Colman and Taubman-Dye class action suit against Theranos as well as Theranos’ other legal challenges and chronicles the final demise of the company in 2019.  View Details
      Keywords: health testing And trials; Corporate Accountability; Organizational Culture; Misleading And Fraudulent Advertising; Crime And Corruption; Entrepreneurship; Lawsuits And Litigation; Business Exit Or Shutdown; Medical Devices And Supplies Industry; California; United States
      Citation
      Educators
      Purchase
      Related
      Hsieh, Nien-he, Christina R. Wing, and John Masko. "Theranos: Who Has Blood on Their Hands? (B)." Harvard Business School Case 320-091, February 2020.
      • January 2020
      • Article

      The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System

      By: Peter P. Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry and Mark J. Pirwitz
      Background. A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. Multiple publications and corrections of prior data were performed, and the United States Food and Drug Administration has...  View Details
      Keywords: Medical Devices; health testing And trials; Analysis; Sales
      Citation
      Read Now
      Related
      Monteleone, Peter P., Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry, and Mark J. Pirwitz. "The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System." Journal of Invasive Cardiology 32, no. 1 (January 2020).
      • October 2019 (Revised April 2020)
      • Background Note

      Note on Funding Deep Tech Startups

      By: Karim Lakhani, Peter Barrett and Noubar Afeyan
      This Background Note provides essential information on funding deep technologies—those technologies that were inherently capital intensive, time consuming, risky, and potentially disruptive. Both dilutive and non-dilutive sources of investment are highlighted, along...  View Details
      Keywords: Entrepreneurship; Energy; Venture Capital; Corporate Finance; Initial Public Offering; Investment; health testing And trials; Innovation And Invention; Technological Innovation; Intellectual Property; Product Design; Product Development; Technology; Research And Development; Risk And Uncertainty; Technology Industry; Biotechnology Industry; United States; North America; Europe; Asia
      Citation
      Educators
      Purchase
      Related
      Lakhani, Karim, Peter Barrett, and Noubar Afeyan. "Note on Funding Deep Tech Startups." Harvard Business School Background Note 620-029, October 2019. (Revised April 2020.)
      • October 2019
      • Article

      Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations

      By: Derek C. Angus, Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc J. M. Bonten, Mary Brophy, Christopher Butler, Timothy F. Cloughesy, Lennie P. G. Derde, Laura J. Esserman, Ryan Ferguson, Louis Fiore, Sarah C. Gaffey, J. Michael Gaziano, Kathy Giusti, Herman Goossens, Stephane Heritier, Bradley Hyman, Michael Krams, Kay Larholt, Lisa M. LaVange, Philip Lavori, Andrew W. Lo, Alexander J. London, Victoria Manax, Colin McArthur, Genevieve O’Neill, Giovanni Parmigiani, Jane Perlmutter, Elizabeth A. Petzold, Craig Ritchie, Kathryn M. Rowan, Christopher W. Seymour, Nathan I. Shapiro, Diane M. Simeone, Bradley Smith, Bradley Spellberg, Ariel Dora Stern, Lorenzo Trippa, Mark Trusheim, Kert Viele, Patrick Y. Wen and Janet Woodcock
      Researchers, clinicians, policymakers, and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to answer with traditional, free-standing, parallel-group randomized controlled trials (RCTs). Examples include...  View Details
      Keywords: Adaptive Platform Trials; health testing And trials
      Citation
      Find at Harvard
      Read Now
      Related
      Angus, Derek C., Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc J. M. Bonten, Mary Brophy, Christopher Butler, Timothy F. Cloughesy, Lennie P. G. Derde, Laura J. Esserman, Ryan Ferguson, Louis Fiore, Sarah C. Gaffey, J. Michael Gaziano, Kathy Giusti, Herman Goossens, Stephane Heritier, Bradley Hyman, Michael Krams, Kay Larholt, Lisa M. LaVange, Philip Lavori, Andrew W. Lo, Alexander J. London, Victoria Manax, Colin McArthur, Genevieve O’Neill, Giovanni Parmigiani, Jane Perlmutter, Elizabeth A. Petzold, Craig Ritchie, Kathryn M. Rowan, Christopher W. Seymour, Nathan I. Shapiro, Diane M. Simeone, Bradley Smith, Bradley Spellberg, Ariel Dora Stern, Lorenzo Trippa, Mark Trusheim, Kert Viele, Patrick Y. Wen, and Janet Woodcock. "Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations." Nature Reviews: Drug Discovery 18, no. 10 (October 2019): 797–807.
      • September 2019
      • Supplement

      Adaptive Platform Trials: The Clinical Trial of the Future? (B)

      By: Ariel D. Stern and Sarah Mehta
      This case provides an update to the (A) case, which introduces students to adaptive platform trials, an ambitious, more efficient type of clinical trial that increases access to therapies. The (A) case centers on Dr. Brian Alexander’s efforts to launch an adaptive...  View Details
      Keywords: Clinical Trials; Drug Trials; Drug Testing; Cancer Trials; Glioblastoma; Platform Trials; Adaptive Trials; Adaptive Platform Trials; health testing And trials; health Care And Treatment; Financing And Loans; Business Strategy; health Industry; United States
      Citation
      Purchase
      Related
      Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future? (B)." Harvard Business School Supplement 620-001, September 2019.
      • February 2019 (Revised February 2020)
      • Case

      Theranos: Who Has Blood on Their Hands? (A)

      By: Nien-hê Hsieh, Christina R. Wing, Emilie Fournier and Anna Resman
      This case covers the rise and fall of Theranos, the company founded by Elizabeth Holmes in 2004 to revolutionize the blood testing industry by creating a device that could provide from a small finger prick the same results and accuracy as intravenous blood draws. As...  View Details
      Keywords: health testing And trials; Corporate Accountability; Organizational Culture; Misleading And Fraudulent Advertising; Crime And Corruption; Ethics; Entrepreneurship; Lawsuits And Litigation
      Citation
      Educators
      Purchase
      Related
      Hsieh, Nien-hê, Christina R. Wing, Emilie Fournier, and Anna Resman. "Theranos: Who Has Blood on Their Hands? (A)." Harvard Business School Case 619-039, February 2019. (Revised February 2020.)
      • February 2019 (Revised September 2019)
      • Case

      Theranos: The Unicorn That Wasn't

      By: Joseph B. Fuller and John Masko
      In 2003, 19-year-old Elizabeth Holmes founded a startup dedicated to making blood testing easier and more affordable. By 2015, her company, Theranos, was worth $9 billion. It boasted a star-studded board and contracts with national pharmacy and supermarket chains...  View Details
      Keywords: Theranos; Blood; Lab Testing; Fraud; Holmes; Balwani; Shultz; Carreyrou; Securities And Exchange Commission; Food And Drug Administration; Fda; Sec; health testing And trials; Corporate Accountability; Organizational Culture; Misleading And Fraudulent Advertising; Crime And Corruption; Entrepreneurship; Medical Devices And Supplies Industry
      Citation
      Educators
      Purchase
      Related
      Fuller, Joseph B., and John Masko. "Theranos: The Unicorn That Wasn't." Harvard Business School Case 319-068, February 2019. (Revised September 2019.)
      • March 2018
      • Teaching Note

      Adaptive Platform Trials: The Clinical Trial of the Future?

      By: Ariel D. Stern and Sarah Mehta
      This teaching note provides guidance and recommendations for teaching HBS Case No. 618-025, entitled “Adaptive Platform Trials: The Clinical Trial of the Future?”  View Details
      Keywords: Clinical Trials; Drug Trials; Drug Testing; Cancer Trials; Glioblastoma; Platform Trials; Adaptive Trials; Adaptive Platform Trials; health testing And trials; health Care And Treatment; Business Strategy; health Industry; United States
      Citation
      Purchase
      Related
      Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Teaching Note 618-048, March 2018.
      • January 2018
      • Article

      The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials

      By: Aaron V. Kaplan and Ariel Dora Stern
      The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of...  View Details
      Keywords: health testing And trials; Business And Government Relations; Governing Rules, Regulations, And Reforms; Information Publishing; Medical Devices And Supplies Industry; United States
      Citation
      Find at Harvard
      Related
      Kaplan, Aaron V., and Ariel Dora Stern. "The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials." JAMA Cardiology 3, no. 1 (January 2018): 5–6.
      • September 2017 (Revised January 2018)
      • Case

      Adaptive Platform Trials: The Clinical Trial of the Future?

      By: Ariel D. Stern and Sarah Mehta
      In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer....  View Details
      Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; health; health Care And Treatment; health testing And trials; Business Strategy; Innovation Strategy; health Industry; United States
      Citation
      Educators
      Purchase
      Related
      Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised January 2018.)
      • September 2017 (Revised February 2018)
      • Case

      Becton Dickinson: Global Health Strategy

      By: Mark R. Kramer and Sarah Mehta
      Becton, Dickinson and Company (BD) was a medical technology firm headquartered in Franklin Lakes, New Jersey, with 43,000 employees and 2016 revenues of $12.5 billion. For several years, the company had pursued developing products that created shared value, defined as...  View Details
      Keywords: Shared Value; Creating Shared Value; Odon Device; Medical Technology; Value Creation; Values And Beliefs; Philanthropy And Charitable Giving; health; health Care And Treatment; health testing And trials; Emerging Markets; Social Issues; Competitive Strategy; Medical Devices And Supplies Industry; Africa; Asia; Middle East
      Citation
      Educators
      Purchase
      Related
      Kramer, Mark R., and Sarah Mehta. "Becton Dickinson: Global Health Strategy." Harvard Business School Case 718-406, September 2017. (Revised February 2018.)
      • January 2017
      • Supplement

      Terrapin Laboratory: Exercise

      By: Joseph B. Fuller and Christopher Payton
      In this exercise, we examine the capital requirements of Terrapin Laboratory as they contemplate entering into a new market segment. The company is faced with two potential financing options which have different effects on the ownership structure of the company....  View Details
      Keywords: Business Growth; Entrepreneurial Management; Entrepreneurship; Growth Strategy; Market Entry; Venture Capital; Venture Capital; Market Entry And Exit; Entrepreneurship; health testing And trials; Growth And Development Strategy; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Fuller, Joseph B., and Christopher Payton. "Terrapin Laboratory: Exercise." Harvard Business School Spreadsheet Supplement 317-704, January 2017.
      • 1
      • 2
      • 3
      • →

      Are you looking for?

      Health Testing and Trials
      Skip to Main Content Cold Call A podcast featuring faculty discussing cases they've written and the lessons they impart. Subscribe on iTunes 29 Sep...
      The Race for a Vaccine
      Above: illustration by Matthew Roharik/Getty Images In November 2019, a team from the National Institute of Allergy and Infectious Diseases, part of...
      → Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College